506938 — Kappac Pharma Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareMicro Cap
Annual cashflow statement for Kappac Pharma, fiscal year end - March 31st, millions except per share.
2017 March 31st | 2018 March 31st | 2019 March 31st | 2020 March 31st | 2021 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | 12 M | 12 M |
| Source: | PRESS | PRESS | |||
| Standards: | — | — | — | — | — |
| Status: | fx Preliminary | fx Preliminary | fx Preliminary | Final | Final |
| Net Income/Starting Line | — | — | — | -0.153 | -22 |
| Depreciation | |||||
| Non-Cash Items | — | — | — | 0 | 0 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | — | — | — | 7.2 | -5.31 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | — | — | — | 7.05 | -27.3 |
| Capital Expenditures | — | — | — | 0 | 0 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | — | 13.2 | 27.3 |
| Sale/Maturity of Investment | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | — | — | — | 13.2 | 27.3 |
| Financing Cash Flow Items | — | — | — | 0 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | — | — | — | 6.1 | 0 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | — | — | — | 26.3 | -0.002 |